Question 1

What is PACB's ST Score?

Accepted Answer

Pacific Biosciences of California, Inc. (PACB) has an ST Score of 39.8 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Question 2

Is PACB a buy, hold, or sell?

Accepted Answer

Analysts rate PACB a Buy, with a price target of $1.18 (-25.3% vs the current price). Our ST Score grades it C (39.8/100). The ST Score is a data-driven signal, not a recommendation.

Question 3

What are PACB's factor grades?

Accepted Answer

Valuation A-, Profitability D+, Financial Strength B-, Momentum A-, Growth C-, Forecast C, Sentiment F.

Question 4

What is PACB's valuation grade?

Accepted Answer

Pacific Biosciences of California, Inc. (PACB) earns a valuation grade of A-, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

Question 5

What is PACB's growth grade?

Accepted Answer

Pacific Biosciences of California, Inc. (PACB) earns a growth grade of C-, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

Question 6

What is PACB's profitability grade?

Accepted Answer

Pacific Biosciences of California, Inc. (PACB) earns a profitability grade of D+, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

Question 7

What is PACB's financial strength grade?

Accepted Answer

Pacific Biosciences of California, Inc. (PACB) earns a financial strength grade of B-, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

Question 8

What is the analyst price target for PACB?

Accepted Answer

The average analyst price target for Pacific Biosciences of California, Inc. (PACB) is $1.18 from 18 analysts, which is -25.3% versus the recent price of $1.58.

Question 9

What is PACB's Piotroski score?

Accepted Answer

Pacific Biosciences of California, Inc. (PACB) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.

Pacific Biosciences of California, Inc. (PACB) Dividends & Stock Splits History

Does PACB pay a dividend?

How do stock dividends work?

What is PACB's dividend yield and growth rate?

Are PACB's dividends safe?

What is the current Pacific Biosciences of California, Inc. (PACB) stock price?

What sector and industry does PACB operate in?

What is PACB's market cap?

How many employees does PACB have?